Company intelligence / Profile preview

Herba Tread

Ownership: Private
Development stage: Other

Overview

HerbaTread is a biotechnology company focused on the development of novel therapeutic interventions for neurodegenerative diseases, specifically Alzheimer's disease. The company leverages natural product-derived small molecules to target the underlying pathology of cognitive decline, including amyloid-beta aggregation and tau phosphorylation. HerbaTread's research aims to bridge the gap between traditional herbal medicine and modern pharmacological standards to provide safe and effective treatments. Their lead programs are currently in the pre-clinical stage, focusing on neuroprotection and memory enhancement.

Therapeutic areas: Neurology
Modalities: Small moleculeNatural product
Industry: Biotech

Beyond the preview

Go deeper on Herba Tread.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herba Tread.

Explore the full profile